FDA Drug Application (021713) for ABILIFY by OTSUKA

Back to FDA Applications sponsored by OTSUKA

Application Number021713
Product Number001
FormSOLUTION;ORAL
Dosage1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY
Active IngredientARIPIPRAZOLE



Back to FDA Applications sponsored by OTSUKA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.